GeneLink Inc. restated unaudited earnings results for the three months ended March 31, 2011, second quarter and six months ended June 30, 2011 and third quarter and nine months ended September 30, 2011. For the three months, operating loss restated amounts to $487,380 against reported amount of $444,642; net loss restated is $592,496 against reported amount of $568,459. For the second quarter ended June 30, 2011, operating loss restated amounts to $813,373 against reported amount of $772,832; net loss restated amounts to $826,416 against net loss reported amount of $801,533. For the six months ended June 30, 2011, operating loss restated amounts to $1,294,160 against reported amount of $1,210,881; net loss restated amounts to $1,418,912 against net loss reported amount of $1,369,992. For the third quarter ended September 30, 2011, operating loss restated amounts to $916,838 against reported amount of $880,009; net loss restated amounts to $978,267 against net loss reported amount of $954,230. For the nine months ended September 30, 2011, operating loss restated amounts to $2,261,000 against reported amount of $2,140,892; net loss restated amounts to $2,163,847 against net loss reported amount of $2,090,890.